• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MiR-451对紫杉醇耐药乳腺癌细胞系耐药性的影响

Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line.

作者信息

Gu Xi, Li Jian-Yi, Guo Jiao, Li Pi-Song, Zhang Wen-Hai

机构信息

Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China (mainland).

出版信息

Med Sci Monit. 2015 Oct 30;21:3291-7. doi: 10.12659/msm.894475.

DOI:10.12659/msm.894475
PMID:26516138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4630958/
Abstract

BACKGROUND

This study aimed to investigate the potential influence of microRNA-451 (miR-451) in drug resistances of the Paclitaxel-resistant breast cancer cell line by transfecting miR-451 mimics and miR-451 inhibitors to MCE-7, MCF-7/EPI, and MCF-7/DOC.

MATERIAL AND METHODS

Real-time quantitative PCR (qRT-PCR) was performed for detecting whether transfected miR-451 mimics and miR-451 inhibitors could regulate the expression of miR-451 effectively. The apoptosis of the 3 cell lines was measured by applying Annexin V-APC/PI staining. Western blot was used for the detection of the protein expression of Bcl-2 and Caspase 3 after the transfection of miR-451 mimics /inhibitors. Bioinformatics analysis demonstrated that Bcl-2 protein is a potential target gene for miR-451.

RESULTS

In comparison to the control group, after transfection with miR-451 mimics, there was a significant increase in miR-451 expression in MCF-7, MCF-7/EPI, and MCF-7/DOC. Cells in the three cell lines had increased apoptosis, Bcl-2 protein expression decreased significantly, and Caspase protein expression increased obviously. After the transfection with miR-451 inhibitors, miR-451 expression was significantly decreased and apoptosis in the 3 cell lines had no significant decrease compared with the control group.

CONCLUSIONS

Increased miR-451 expression may negatively regulate Bcl-2 mRNA and protein expression, followed by affecting the protein expression of caspase 3, and accelerate the apoptosis in breast cancer, indicating that miR-451 might influence the drug resistances of the Paclitaxel-resistant breast cancer cell line.

摘要

背景

本研究旨在通过将微小RNA - 451(miR - 451)模拟物和miR - 451抑制剂转染至MCE - 7、MCF - 7/EPI和MCF - 7/DOC细胞,研究miR - 451对耐紫杉醇乳腺癌细胞系耐药性的潜在影响。

材料与方法

采用实时定量聚合酶链反应(qRT - PCR)检测转染的miR - 451模拟物和miR - 451抑制剂是否能有效调节miR - 451的表达。应用膜联蛋白V - APC/PI染色检测3种细胞系的凋亡情况。转染miR - 451模拟物/抑制剂后,采用蛋白质印迹法检测Bcl - 2和半胱天冬酶3的蛋白表达。生物信息学分析表明Bcl - 2蛋白是miR - 451的潜在靶基因。

结果

与对照组相比,转染miR - 451模拟物后,MCF - 7、MCF - 7/EPI和MCF - 7/DOC细胞中miR - 451表达显著增加。三种细胞系的细胞凋亡增加,Bcl - 2蛋白表达显著降低,半胱天冬酶蛋白表达明显增加。转染miR - 451抑制剂后,miR - 451表达显著降低,与对照组相比,三种细胞系的凋亡无显著下降。

结论

miR - 451表达增加可能负向调节Bcl - 2 mRNA和蛋白表达,进而影响半胱天冬酶3的蛋白表达,加速乳腺癌细胞凋亡,表明miR - 451可能影响耐紫杉醇乳腺癌细胞系的耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/dbbcf595730b/medscimonit-21-3291-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/be6a4bdd5abd/medscimonit-21-3291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/07bdee203f61/medscimonit-21-3291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/b1255e7e748c/medscimonit-21-3291-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/dbbcf595730b/medscimonit-21-3291-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/be6a4bdd5abd/medscimonit-21-3291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/07bdee203f61/medscimonit-21-3291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/b1255e7e748c/medscimonit-21-3291-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0aa/4630958/dbbcf595730b/medscimonit-21-3291-g004.jpg

相似文献

1
Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line.MiR-451对紫杉醇耐药乳腺癌细胞系耐药性的影响
Med Sci Monit. 2015 Oct 30;21:3291-7. doi: 10.12659/msm.894475.
2
[Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells].[微小RNA-21对人乳腺癌细胞紫杉醇耐药性的影响]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jul;44(4):400-9. doi: 10.3785/j.issn.1008-9292.2015.07.09.
3
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.微小RNA-218靶向存活素并调节乳腺癌对化疗药物的耐药性。
Breast Cancer Res Treat. 2015 Jun;151(2):269-80. doi: 10.1007/s10549-015-3372-9. Epub 2015 Apr 22.
4
Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.循环微RNA-451作为乳腺癌新辅助化疗耐药的预测指标
Cancer Biomark. 2016;16(3):395-403. doi: 10.3233/CBM-160578.
5
MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.miR-222 和 miR-29a 有助于乳腺癌细胞的耐药性。
Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.
6
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 pathway.微小RNA-222通过PTEN/Akt/p27信号通路诱导乳腺癌对阿霉素产生耐药性。
Tumour Biol. 2016 Nov;37(11):15315-15324. doi: 10.1007/s13277-016-5341-2. Epub 2016 Oct 4.
7
Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel.Bcl-2/Bax 比值、半胱天冬酶-8和9在乳腺癌细胞对紫杉醇耐药性中的作用
Asian Pac J Cancer Prev. 2014;15(20):8617-22. doi: 10.7314/apjcp.2014.15.20.8617.
8
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.miR-195 的上调通过抑制 Raf-1 增加了乳腺癌细胞对阿霉素治疗的敏感性。
Oncol Rep. 2013 Aug;30(2):877-89. doi: 10.3892/or.2013.2532. Epub 2013 Jun 11.
9
MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.miR-155-5p 通过 TP53INP1 促进人乳腺癌肿瘤进展并导致紫杉醇耐药。
Pathol Res Pract. 2021 Apr;220:153405. doi: 10.1016/j.prp.2021.153405. Epub 2021 Mar 5.
10
[miR-16-5p regulates apoptosis and migration of drug-resistant breast cancer cells by targeting YWHAQ].[微小RNA-16-5p通过靶向14-3-3蛋白θ调节耐药乳腺癌细胞的凋亡和迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Oct 20;42(10):1476-1485. doi: 10.12122/j.issn.1673-4254.2022.10.06.

引用本文的文献

1
Ferroptosis emerges as the predominant form of regulated cell death in goat sperm cryopreservation.铁死亡是山羊精子冷冻保存中调节性细胞死亡的主要形式。
J Anim Sci Biotechnol. 2025 Feb 18;16(1):26. doi: 10.1186/s40104-025-01158-0.
2
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy.乳腺癌:微小RNA监测化疗耐药性及全身治疗
Front Oncol. 2023 Jun 16;13:1155254. doi: 10.3389/fonc.2023.1155254. eCollection 2023.
3
Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment.

本文引用的文献

1
Activation of caspase-dependent apoptosis by intracellular delivery of Cytochrome c-based nanoparticles.通过基于细胞色素c的纳米颗粒的细胞内递送激活半胱天冬酶依赖性凋亡。
J Nanobiotechnology. 2014 Sep 2;12:33. doi: 10.1186/s12951-014-0033-9.
2
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.miR-155 通过靶向 RAD51 在乳腺癌中发挥保护作用,从而在照射后损害同源重组。
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4536-41. doi: 10.1073/pnas.1402604111. Epub 2014 Mar 10.
3
MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
肿瘤微环境中细胞外囊泡介导的胰腺癌与基质细胞之间的串扰
J Nanobiotechnology. 2022 May 2;20(1):208. doi: 10.1186/s12951-022-01382-0.
4
Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.miR-27b 和 miR-451a 的下调表达水平可作为接受 TAC 化疗的三阴性乳腺癌患者的潜在生物标志物。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):1053-1059. doi: 10.31557/APJCP.2022.23.3.1053.
5
Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells.来自爱泼斯坦-巴尔病毒(EBV)毒株M81和B95.8的潜伏膜蛋白1(LMP1)在永生化人鼻咽细胞中表达时可调节miRNA表达。
Genes (Basel). 2022 Feb 16;13(2):353. doi: 10.3390/genes13020353.
6
The Role of Non-Coding RNAs in Breast Cancer Drug Resistance.非编码RNA在乳腺癌耐药中的作用。
Front Oncol. 2021 Sep 13;11:702082. doi: 10.3389/fonc.2021.702082. eCollection 2021.
7
MicroRNAs as a clue to overcome breast cancer treatment resistance.微小 RNA 作为克服乳腺癌治疗耐药性的线索。
Cancer Metastasis Rev. 2022 Mar;41(1):77-105. doi: 10.1007/s10555-021-09992-0. Epub 2021 Sep 15.
8
A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.四种循环 microRNAs 作为早期乳腺癌诊断潜在生物标志物的特征。
Int J Mol Sci. 2021 Jun 6;22(11):6121. doi: 10.3390/ijms22116121.
9
QIMCMDA: MiRNA-Disease Association Prediction by q-Kernel Information and Matrix Completion.QIMCMDA:基于q核信息和矩阵填充的微小RNA-疾病关联预测
Front Genet. 2020 Oct 22;11:594796. doi: 10.3389/fgene.2020.594796. eCollection 2020.
10
Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer.连接缺失的环节:非编码RNA作为乳腺癌治疗敏感性的关键调节因子
Cancers (Basel). 2020 Sep 21;12(9):2698. doi: 10.3390/cancers12092698.
微小 RNA 表达谱可区分脂肪肉瘤亚型,并提示 miR-145 和 miR-451 为肿瘤抑制因子。
Int J Cancer. 2014 Jul 15;135(2):348-61. doi: 10.1002/ijc.28694. Epub 2014 Jan 16.
4
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
5
The potential role of miR-451 in cancer diagnosis, prognosis, and therapy.miR-451 在癌症诊断、预后和治疗中的潜在作用。
Mol Cancer Ther. 2013 Jul;12(7):1153-62. doi: 10.1158/1535-7163.MCT-12-0802. Epub 2013 Jun 27.
6
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.miR-195 的上调通过抑制 Raf-1 增加了乳腺癌细胞对阿霉素治疗的敏感性。
Oncol Rep. 2013 Aug;30(2):877-89. doi: 10.3892/or.2013.2532. Epub 2013 Jun 11.
7
The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.局部晚期三阴性乳腺癌新辅助含铂化疗的应用:144 例患者的回顾性分析。
Breast Cancer Res Treat. 2013 Apr;138(3):783-94. doi: 10.1007/s10549-013-2497-y. Epub 2013 Mar 31.
8
Risk of ischemic heart disease in women after radiotherapy for breast cancer.乳腺癌放疗后女性患缺血性心脏病的风险。
N Engl J Med. 2013 Mar 14;368(11):987-98. doi: 10.1056/NEJMoa1209825.
9
The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer.新辅助化疗的反应可预测临床结局,并增加晚期乳腺癌的保乳机会。
Am J Surg. 2013 Jul;206(1):2-7. doi: 10.1016/j.amjsurg.2012.10.025. Epub 2013 Jan 31.
10
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.ABT-199,一种强效和选择性的 BCL-2 抑制剂,在发挥抗肿瘤活性的同时不影响血小板。
Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6.